- Vouliez-vous dire
- part
Résultats de la recherche - 2 results
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: Results of the second data collection (28/09/21-23/02/22)
this time period. During the second period of wave 2 (25/10-21/11) the prevalence increased further to 92.9%. Among the fully vaccinated having received the last dose (eventually a booster) in the past ...
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study
vaccination in the past vaccination season boosts the immune response to vaccination against SARS-CoV-2. People vaccinated with a nucleic acid vaccine (Pfizer, Moderna) are more likely to have anti‑ SARS ‑CoV‑2 ...